MTOR and hepatocellular carcinoma: For example, the activation of many critical pathways, including Ras/Raf/MAPK, PI3K/AKT/mTOR, Wnt/β-catenin signaling pathways, ubiquitin/proteasome degradation, and the hedgehog signaling pathway, might lead to novel therapeutics for HCC treatment 64.